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A B S T R A C T   
Background: Solar ultraviolet radiation (UVR) affects the body through pathways that exhibit positive as well as 
negative health effects such as immunoregulation and vitamin D production. Different vitamin D metabolites are 
associated with higher or lower concentrations of estrogens and may thus alter the female sex hormone balance. 
Objective: To study whether exposure to UVR, as a modifiable lifestyle factor, is associated with levels of sex 
hormones (17β-estradiol, estrone, estrone 3-sulfate, testosterone, dehydroepiandrosterone sulfate), gonadotro-
pins (follicle stimulating hormone, luteinizing hormone) as well as sex hormone binding globulin in post-
menopausal women, and thus investigate whether managing UVR exposure can influence the hormone balance, 
with potential benefits for the biological aging process. 
Abbreviations: CI, confidence interval; cL, centiliter; CV, coefficient of variation; daL, dekaliter; DHEA-S, dehydroepiandrosterone sulfate; dL, deciliter; ECRHS, 
European Community respiratory health survey; FSH, follicle stimulating hormone; IQR, interquartile range; LLQ, lower limit of quantification; IU/L, international 
units per liter; LC–MS/MS, liquid chromatography–tandem mass spectrometry; LH, luteinizing hormone; SHBG, sex hormone binding globulin; SED, standard er-
ythema dose; UVR, ultraviolet radiation. 
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Methods: The study included 580 postmenopausal women from six European countries, participating in the 
European Community Respiratory Health Survey (2010–2014). Average UVR exposure during the month before 
blood sampling was estimated based on personal sun behavior and ambient levels. Hormone concentrations were 
measured in serum using state-of-the-art methods. Subsequently we applied linear mixed-effects models, 
including center as random intercept, hormone concentrations (one at a time) as outcome and UVR, age, skin 
type, body mass index, vitamin D from dietary sources, smoking, age at completed full-time education and season 
of blood sampling as fixed-effect predictors. 
Results: One interquartile range increase in UVR exposure was associated with decreased levels of 17β-estradiol 
(-15.6 pmol/L, 95 % Confidence Interval (CI): -27.69, -3.51) and estrone (-13.36 pmol/L, 95 % CI: -26.04, -0.68) 
and increased levels of follicle stimulating hormone (9.34IU/L, 95 % CI: 2.91, 15.77) and luteinizing hormone 
(13.86 IU/daL, 95 % CI: 2.48, 25.25). 
Conclusions: Exposure to UVR is associated with decreased estrogens and increased gonadotropins in post-
menopausal women, a status associated with osteoporosis, lung function decline and other adverse health effects. 
This study indicates that managing UVR exposure has potential to influence the hormone balance and counteract 
adverse health conditions after menopause.   
1. Introduction 
After menopause the female hormone balance changes drastically [1, 
2]. Low concentrations of estrogens and rising concentrations of go-
nadotropins affect many physiological pathways and accelerate the 
aging process [3]. Existing evidence suggests that this development may 
be influenced by utilizing lifestyle modifications to enhance the post-
menopausal quality of life [4,5]. One easily modifiable lifestyle factor is 
the exposure to sunlight and thus ultraviolet radiation (UVR), which is a 
form of non-ionizing radiation that has both adverse and beneficial 
health effects. The sun is the principal source of UVR exposure, with 
short-term effects such as photokeratitis, sunburn and immunosup-
pression and long-term effects such as skin cancers, skin photoaging and 
cataracts [6]. A main known benefit of UVR is the stimulation of vitamin 
D production in the skin, which is essential for the calcium metabolism 
and for the maintenance of the musculoskeletal system [6,7]. Vitamin D 
in turn has been associated with endogenous concentrations of estro-
gens, as e.g. women with lower vitamin D were found to also have lower 
mean concentrations of 17β-estradiol across the menstrual cycle [8] and 
1,25-dihydroxy vitamin D stimulates 17β-estradiol production [9]. A 
recent comprehensive review further highlights that vitamin D metab-
olizing enzymes are expressed in human reproductive tissues and that 
vitamin D deficiency is linked with impaired hormone production, thus 
attributing a mechanistic role for vitamin D in steroidogenesis [10]. 
Additionally an in vitro study of placental steroidogenesis showed, that 
calcitriol is a physiological regulator of 17β-estradiol [11]. Although, 
several studies suggest a link between concentrations of sex hormones 
and UVR exposure, to date there is no direct evidence on such a rela-
tionship [10,12,13]. We hypothesize that UVR exposure may affect the 
hormonal balance in postmenopausal women, which is of public health 
interest, as estrogens contribute to healthier reproductive aging through 
less pulmonary inflammation [14,15], faster wound healing and pre-
vention of osteoporosis [16,17], while high gonadotropins are associ-
ated with lower cognitive function and a higher risk for Alzheimer’s 
Disease [18]. The aim of the present study was to investigate whether 
UVR exposure is associated with serum concentrations of sex hormones, 
gonadotropins and sex hormone binding globulin (SHBG) after meno-
pause and thus study whether managing UVR exposure can influence the 
hormone balance, with potential benefits for the biological aging 
process. 
2. Methods 
2.1. Study population 
The present analysis was based on the second follow-up of the Eu-
ropean Community Respiratory Health Survey (ECRHS), a population- 
based cohort study [19,20] that recruited random participants 
throughout Europe, reflecting a mostly Caucasian population. The 
current analysis included 580 postmenopausal women from eleven 
study centers in six countries in the south, center and north of Europe 
(Huelva, Albacete and Galdakao in Spain, Bordeaux, Grenoble and Paris 
in France, Aarhus in Denmark, Uppsala and Umea in Sweden, Reykjavik 
in Iceland as well as Bergen in Norway). The examinations took place 
during 2010 and 2014 and consisted of an interviewer-led questionnaire 
on anthropometrics, lifestyle factors, sun behavior and reproductive 
health as well as blood sampling. Vitamin D intake from dietary was 
estimated using the GA2LEN food frequency questionnaire, a standard-
ized instrument, designed to ascertain dietary intake internationally 
[21]. 
We included only women in a stable hormonal state, reporting no 
menstrual periods within the last 12 months, surgical removal of the 
ovaries or FSH serum levels greater or equal to 70 IU/L [1]. Therefore, 
we excluded pre- and perimenopausal women, as well as women who 
reported taking exogenous hormones such as hormone replacement 
therapy or treatments for (not specified) gynecological conditions at the 
time of the survey. Ethical approval was obtained from the appropriate 
ethics committees of each study center and all participants provided 
informed written consent. 
2.2. Individual UVR exposure 
We obtained satellite data on the ambient vitamin D effective UVR 
dose at wave lengths between 290 and 315 nm [22,23] at each study 
center, from the Royal Netherlands Meteorological Society (www.temis. 
nl) [24,25]. These data account for the attenuation of UVR due to clouds, 
varying Sun-Earth distance, axial tilt, surface albedo, surface elevation 
as well as presence of aerosols. Additionally, we collected data on per-
sonal sun behavior, including time spent outdoors during daylight, 
vacation destinations, clothing and frequency of sunscreen use through a 
standardized sun behavior questionnaire (Online data supplement sec-
tion 2). Furthermore we gathered self-reported data on skin type, as an 
indicator of sun sensitivity [26,27]. Subsequently, we applied the 
following modeling approach integrating data on personal sun behavior, 
with data on ambient UVR to estimate the daily exposure [24,28,29]:  
Eid = UVRd × EFid × (1 - (1 - hid / Hd)2)                                                 
where Eid is the facial UVR exposure in subject i during day d, UVRd is 
the ambient UVR level in day d, EFid is the exposure fraction (i.e. the 
fraction of ambient UVR received on the face relative to ambient during 
the same period of exposure in subject i during day d), hid is the time 
spent outdoors during daylight by subject i during day d and Hd is the 
number of daylight hours for the mid-point of the month that includes 
day d and at the latitude of interest. The exposure fraction for subject i 
on day d, EFid, was assumed to be distributed according to a uniform 
probability distribution. Specifically:  
EFid = EFmin, d + ri (EFmax, d – EFmin, d)                                                  
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where EFmin,d and EFmax,d are the minimum and maximum exposure 
fractions on day d for any subject, respectively and ri, between 0 and 1, is 
drawn from the uniform distribution. EFmin,d was set at 0.05 in all cases 
and EFmax,d was set at 0.25, 0.30, 0.40 and 0.50 for the weekdays, winter 
weekends, summer weekends and holidays respectively [28]. We pre-
viously validated the modeling framework against measurements of 
UVR exposure by personal UVR dosimeters in outdoor and indoor 
workers over a period of six months (covering the warm and the cold 
season). Modeled UVR exposure levels strongly correlated with dosim-
eter measured personal UVR exposure levels (correlation coefficient: 
0.87) (Manuscript submitted). 
It was difficult to choose a proper window of exposure because the 
involved pathways were likely to be complex and intertwined. For our 
main analyses, we averaged the daily estimates of UVR exposure over a 
period of one month preceding the examination visit for each partici-
pant, in order to abstract their individualized mean UVR exposure over 
this period. To investigate the robustness of our findings to this choice, 
we abstracted two alternative exposure times of one week and three 
months. We repeated the analyses using these exposure estimates. 
2.3. Serum sex hormone analysis 
Non-fasting blood samples were collected and centrifuged within 
three hours after collection and blood serum was stored at − 80 ◦C until 
analysis. In the current study we included total concentrations of steroid 
hormones (17β-estradiol, estrone, estrone 3-sulfate, testosterone and 
dehydroepiandrosterone sulfate (DHEA-S)), measured with a high 
sensitivity liquid chromatography-tandem mass spectrometry method 
[30] and peptides (follicle stimulating hormone (FSH), luteinizing hor-
mone (LH) and sex hormone binding globulin (SHBG)), determined with 
enzyme-linked immunosorbent assays (Demeditec Diagnostics, Kiel, 
Germany). Measurements were carried out at the Core Facility for 
Metabolomics (University of Bergen, Norway) and all liquid handling 
steps were fully automated [31,32]. Concentrations below the lower 
limit of quantification (LLQ) for 17β-estradiol (3.6 pmol/L), estrone 
(2.1 pmol/L), estrone 3-sulfate (0.24 nmol/L) testosterone 
(106 pmol/L), DHEA-S (0.21 μmol/L), FSH (5.0 IU/L) LH (10.0 IU/L), 
and SHBG (4.0 nmol/L) were included as “lower limit of quantification / 
2” [33]. This was the case for the following percentage of women of our 
study population: 17β-estradiol: 7.0 %, estrone: 0.2 %, estrone 3-sulfate: 
5.1 %, testosterone: 1.4 %, DHEA-S: 0.2 %, FSH: 2.3 %, LH: 0.0 % and 
SHBG: 2.8 %. All assays were specific for the respective compound, only 
LH showed cross reactivity with FSH (2.6 %) and thyroid stimulating 
hormone (1.25 %). 
2.4. Statistical analyses 
We fitted linear mixed effects model with study center as random 
intercept, sex hormones and SHBG (untransformed, as residuals were 
normally distributed) one at a time as outcome and the mean UVR 
exposure during the last month as a fixed effect predictor. Models were 
adjusted for an a priori selected set of covariates: age (continuous), skin 
type (white sensitive; white non-sensitive; olive, brown or black) [34], 
body mass index (continuous), vitamin D intake from dietary sources 
(continuous) [35], smoking habit (lifelong non-smoker, ex-smoker and 
current smoker), age at completed full-time education (<17 years 
(Middle school); 17–20 years (High school); >20 years (University)) as a 
proxy for socio-economic status and season of blood sampling (spring, 
summer, autumn, winter). Missing values for the age at completed 
full-time education (n = 12) where included as “>20 years” for man-
agers and professionals and “17–20 years” for non-manual laborers. 
We fitted several additional models: We 1) repeated the main ana-
lyses using the average UVR exposure during the last week as well as 
during the last three months instead of the last month to approximate 
the window of susceptibility; 2) evaluated the direct association of di-
etary vitamin D intake with hormones; 3) additionally adjusted the 
model of the main analyses for physical activity as total metabolic 
equivalents of task and in a separate model for the answers to the sun 
behavior questions, not included in the exposure assessment: 1. “For the 
last 12 months, where did you spend your summer holidays?” (Options: 
“Home country”, “Mediterranean and Adriatic countries, including 
Northern African”, “Northern European countries, above Brussels”, 
“Central European countries, below Brussels and above Mediterranean 
and Adriatic countries”, “Other”), 2. “During the summer days, which 
parts of your body are usually exposed to sunlight when you are 
outside?” (Options: “Face and hands”, “Arms”, “Legs”, “Trunk” on either 
of the following “Working days”, “Non-working days”, “Holidays”), 3. 
“How often do you use sunscreen when you are outside during the 
summer days?” (Options: “Never”, “Sometimes”, “Usually”, “Always” on 
either of the following “Working days”, “Non-working days”, “Holi-
days”) and 4. “What Sunscreen sun protection factor (SPF) do you 
usually use?” 4) stratified the analysis by season of exposure (winter/ 
spring and summer/autumn), to elaborate the influence of seasonality 
and get an indication of the role of dietary Vitamin D intake, which may 
be of importance for exposure during the winter/spring months but is 
likely negligible during the summer/autumn months; and 5) stratified 
the analysis by skin complexion ("white, sensitive or non-sensitive" and 
"non-white skin type"). All analyses were performed using the R statis-
tical package [36–41] (Fig. 1). 
3. Results 
Anthropometric and endocrine characteristics of the included par-
ticipants are presented in Table 1. The imprecision and accuracy for the 
sex hormone and SHBG measurements is presented in Supplementary 
Table 1. Characteristics of the study population, stratified by skin 
complexion, are presented in Supplementary Table 2. 
The median daily UVR exposure during the last month was 55.1 J/ 
m2 (Interquartile range (IQR): 13.6–163.2 J/m2). Fig. 2 illustrates the 
ambient UVR levels and personal UVR exposure separately for each 
study center. 
The averaged one-month exposure to UVR was associated with 
decreased 17β-estradiol (-15.6 pmol/L, 95 % CI: -27.69, -3.51), estrone 
(-13.36 pmol/L, 95 % CI: -26.04, -0.68) and an increase in concentra-
tions of follicle stimulating hormone (9.34IU/L, 95 % CI: 2.91, 15.77) 
and luteinizing hormone (13.86IU/daL, 95 % CI: 2.48, 25.25) (Fig. 2). 
Further analyses with other exposure windows of one week and three 
months, showed very similar results with overall somewhat lower effect 
sizes (Supplementary Fig. 1 and 2). Investigating the direct association 
of dietary vitamin D intake with hormones did not yield any statistically 
significant results (Supplementary Fig. 3). The analyses with additional 
Fig. 1. Flowchart of the study population with inclusion criteria.  
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adjustment for physical activity and detailed sun behavior resulted in 
similar effect estimates (Supplementary figures 4 and 5). The stratified 
analyses by season of exposure showed stronger associations for expo-
sure during the sun-rich months (Supplementary figures 6 and 7) and 
stratification by skin complexion showed very similar results for white 
skin complexion (Supplementary figure 8), as compared to the whole 
study population, whereas no statistically significant results could be 
observed for non-white skin complexion (Supplementary figure 9) 
(Fig. 3). 
4. Discussion 
In this study we evaluated the association of UVR exposure and 
concentrations of sex hormones and SHBG in postmenopausal women. 
This study used data from a representative sample of women living 
across Europe at different latitudes, cultures and climates. We observed 
that higher exposure to UVR was associated with lower 17β-estradiol 
and estrone levels as well as with elevated FSH and LH levels. This was 
most pronounced for an exposure time of one months as compared to 
one week or three months. Additional adjustment for physical activity 
and personal sun behavior (vacation destination, body exposure and 
sunscreen use) yielded very similar results. We further investigated the 
direct association of dietary vitamin D intake with hormone concen-
trations, without being able to establish statistically significant associ-
ations, indicating that the role of dietary intake of vitamin D is not a 
driving force of the observed associations. The stratified analyses by 
season of exposure showed that the associations were considerably 
stronger for exposure during the sun-rich months, which strengthens the 
hypothesis that dietary vitamin D intake may be negligible. We found 
similar results for women with white skin complexion (compared to the 
main analysis), while for women with non-white skin complexion the 
associations were less clear. This could however be due to the small 
numbers of individuals with non-white skin complexion, decreasing the 
statistical power for the analyses conducted on this subsample. 
To our knowledge, this is the first large-scale epidemiological study 
to combine personal sun behavior with ambient UVR levels. This indi-
vidualization is important, given that most of the variation in actual 
exposure is due to personal behaviors and not due to the ambient, 
latitude-dependent exposure in the place of residence [29,42–44]. Given 
there is no available literature on our studied association, it is not 
possible to compare our findings with those of others; however, our 
results are in line with a number of previous observations, which we 
elaborate below separately for estrogens and gonadotropins. 
It is likely that steroid hormones and gonadotropins are affected by 
different, yet tangled, mechanisms: Sex steroid concentrations are 
directly associated with vitamin D metabolites [9,45], which are derived 
from exposure to UVR radiation, while on the other hand, visible light, 
received by the retina, modulates the actions of the pineal and pituitary 
gland and thus could exhibit an effect on gonadotropins [46,47]. 
4.1. Estrogens 
One possible mechanism explaining the statistically significant 
negative association between estrogens and UVR exposure is based on 
UVR derived vitamin D (cholecalciferol) being metabolized into calci-
diol [48], and 17β-estradiol enhances the conversion of calcidiol to 
calcitriol, the active form of vitamin D, in the kidneys [45]. This 
pathway might also, at least in part, explain the observed association on 
estrone, a metabolic intermediate of 17β-estradiol [9]. This mechanism 
may be further supported by vitamin D being stored in adipose tissue, 
the major estrogen production site in postmenopausal women [49]. 
4.2. Gonadotropins 
We observed a statistically significant positive association with the 
gonadotropins FSH and LH, which are closely related to each other and 
to estrogens through negative feedback regulation. When the gonadal 
production of estrogens stops due to menopause, the gonadotropins rise. 
Therefore, lower estrogen concentrations due to UVR exposure may also 
promote higher concentrations of gonadotropins. Further, bright versus 
dim light exposure has been associated with increased concentrations of 
gonadotropins as well as more ovulatory cycles [50]. A study on light 
therapy, for example, has suggested a direct action of visible light on the 
Table 1 
Description of the study population; Median [interquartile range] for 
continuous variables and number (%) for categorical variables;  
N 580 
Age [years] 56.8 [52.4, 61.4] 
BMI [kg/m2] 25.6 [23.0, 29.4] 
Smoking habit  
Lifelong non-smoker 274 (47.2) 
Ex-smoker 224 (38.6) 
Current smoker 82 (14.1) 
Skin type  
White, sensitive 110 (19.0) 
White, non-sensitive 341 (58.8) 
Olive, brown or black 129 (22.2) 
Dietary vitamin D [μg/d] 7.0 [4.4, 11.0] 
Age at completed education  
<17 years 110 (19.0) 
17–20 years 178 (30.7) 
>20 years 292 (50.3) 
Sex hormones and SHBG  
17β-Estradiol [pmol/L] 12.2 [6.6, 26.8] 
Estrone [pmol/L] 67.8 [47.9, 108.4] 
Estrone 3-sulfate [pmol/cL] 9.0 [5.0, 18.9] 
Testosterone [pmol/dL] 53.0 [36.5, 69.9] 
DHEA-S [nmol/dL] 166.0 [100.6, 251.6] 
FSH [IU/L] 125.7 [84.1, 166.2] 
LH [IU/daL] 278.8 [203.0, 362.0] 
SHBG [nmol/L] 58.9 [36.5, 91.1]  
Fig. 2. Ambient UVR levels and personal UVR exposure by study center, ar-
ranged by geographical latitude from south to north; Cumulative annual 
ambient UVR levels are displayed as horizontal lines and cumulative annual 
personal UVR exposures are displayed as boxplots. The lower and upper hinges 
correspond to the 25th and 75th percentile. The upper and lower whiskers 
extend from the hinge to the largest, respectively smallest value, yet no further 
than 1.5 interquartile ranges. Data beyond the end of the whiskers are plotted 
individually. 
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hypothalamic–pituitary–gonadal axis [51], modulation of the actions of 
the pineal and pituitary gland, and thus an effect on gonadotropins [46, 
47]. It seems plausible, that brighter light occurs predominantly out-
doors, which is also where UVR exposure takes place. This simultaneous 
exposure likely contributes to the results on gonadotropins. Moreover, 
there is evidence that LH is negatively associated with melatonin, which 
accumulates in the pineal gland during daylight hours and secretion is 
restricted until darkness [47]. It is however unclear in how far this might 
be relevant to our observed findings. 
4.3. Strengths and limitations 
The major strengths of this study are the representative study pop-
ulation, state-of-the-art hormone measurements and the individualized 
exposure assessment. The cross-sectional design on the other hand 
limited the capability in establishing a causal relationship. It seems 
however considerably more likely that exposure to UVR is the cause, 
rather than the consequence of an altered hormone balance. A limitation 
of the study is that the dietary assessment of vitamin D did not include 
supplements or medication and that serum vitamin D levels were not 
available, which restricted our ability to evaluate the mechanisms un-
derlying the associations between UVR exposure and sex hormone 
concentrations. Further, melatonin measurements would have allowed a 
more detailed insight into mechanisms at work and we cannot exclude 
that factors such as shift work [52], high intensity physical activity [53] 
or the exclusion of women receiving hormonal treatment may have 
influenced our observed associations somewhat. 
4.4. Conclusions 
We conclude, that high exposure to UVR is associated with an 
adverse hormone balance in postmenopausal women and may nega-
tively affect healthy aging of a large part of the population. This study 
indicates, that managing UVR exposure has potential to influence the 
hormone balance and counteract adverse health conditions after 
menopause. Future studies continuing this pioneering work and 
focusing on pathways, could consider including several vitamin me-
tabolites, not only the routinely measured vitamin D3. 
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